Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHaleon Share News (HLN)

Share Price Information for Haleon (HLN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 322.60
Bid: 323.00
Ask: 323.10
Change: -4.30 (-1.32%)
Spread: 0.10 (0.031%)
Open: 328.50
High: 330.70
Low: 322.20
Prev. Close: 326.90
HLN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Goldman likes Sainsbury's; RBC cuts Imperial

Fri, 08th Dec 2023 09:39

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

----------

FTSE 100

----------

UBS raises Rolls-Royce price target to 400 (350) pence - 'buy'

----------

Deutsche Bank raises Rolls-Royce price target to 400 (310) pence - 'buy'

----------

Deutsche Bank raises BAE Systems target to 1,290 (1,220) pence - 'buy'

----------

Kepler Cheuvreux raises Pearson price target to 915 (810) pence - 'reduce'

----------

Kepler Cheuvreux raises Informa price target to 900 (850) pence - 'buy'

----------

Kepler Cheuvreux cuts Relx to 'hold' (buy) - price target 3,100 (2,915) pence

----------

Redburn raises Lloyds Banking to 'neutral' - price target 50 pence

----------

Goldman Sachs raises J Sainsbury to 'buy' (neutral) - price target 350 (305) pence

----------

Goldman Sachs cuts Haleon price target to 360 (365) pence - 'buy'

----------

Barclays raises Frasers Group price target to 1,085 (1,060) pence - 'overweight'

----------

RBC cuts Taylor Wimpey price target to 135 (145) pence - 'sector perform'

----------

RBC cuts Barratt Developments target to 500 (550) pence - 'sector perform'

----------

RBC cuts British American Tobacco price target to 2,900 (3,500) pence - 'sector perform'

----------

UBS cuts British American Tobacco price target to 2,900 (3,800) pence - 'buy'

----------

RBC cuts Imperial Brands to 'sector perform' (outperform) - price target 1,800 (2,200) pence

----------

JPMorgan cuts Weir Group price target to 2,075 (2,400) pence - 'overweight'

----------

JPMorgan cuts Spirax-Sarco Engineering price target to 10,300 (10,500) pence - 'overweight'

----------

JPMorgan cuts Smiths Group price target to 1,910 (1,980) pence - 'overweight'

----------

JPMorgan cuts IMI price target to 1,850 (1,920) pence - 'overweight'

----------

JPMorgan cuts Ashtead Group price target to 5,600 (5,800) pence - 'overweight'

----------

FTSE 250

----------

SocGen raises Watches of Switzerland price target to 864 (770) pence - 'buy'

----------

Berenberg raises Moonpig price target to 265 (250) pence - 'buy'

----------

Jefferies cuts Moonpig price target to 230 (240) pence - 'buy'

----------

Kepler Cheuvreux cuts ITV price target to 95 (106) pence - 'buy'

----------

Barclays raises AJ Bell price target to 330 (310) pence - 'equal weight'

----------

RBC cuts Vistry price target to 750 (850) pence - 'underperform'

----------

RBC cuts Redrow price target to 750 (825) pence - 'outperform'

----------

RBC cuts Persimmon price target to 1,175 (1,300) pence - 'sector perform'

----------

RBC cuts Crest Nicholson price target to 175 (205) pence - 'underperform'

----------

RBC cuts Bellway price target to 3,050 (3,400) pence - 'outperform'

----------

JPMorgan cuts Vesuvius price target to 460 (470) pence - 'neutral'

----------

JPMorgan raises Spectris price target to 2,900 (2,850) pence - 'underweight'

----------

JPMorgan cuts Rotork price target to 310 (330) pence - 'neutral'

----------

JPMorgan cuts Oxford Instruments target to 2,500 (2,850) pence - 'overweight'

----------

JPMorgan cuts Bodycote price target to 580 (670) pence - 'neutral'

----------

Barclays cuts Future price target to 900 (1,080) pence - 'overweight'

----------

JPMorgan cuts Future price target to 1,555 (1,685) pence - 'overweight'

----------

SMALL CAP

----------

Citigroup raises Wise price target to 590 (560) pence - 'sell'

----------

RBC cuts MJ Gleeson price target to 550 (575) pence - 'outperform'

----------

Citigroup starts Kingspan with 'neutral' - price target 75 EUR

----------

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
26 Jun 2024 17:04

LONDON MARKET CLOSE: CAC 40 underperforms amid political uncertainty

(Alliance News) - Stock prices in London closed lower on Wednesday, with eyes on two days of key US economic data to close of the week.

Read more
26 Jun 2024 15:32

London close: Stocks finish choppy day in the red

(Sharecast News) - London stocks ended in negative territory on Wednesday, influenced by a downturn in retail sales data for June.

Read more
26 Jun 2024 13:04

TOP NEWS: Haleon sells NRT business outside of US for GBP500 million

(Alliance News) - Haleon PLC on Wednesday said it has agreed to sell its nicotine replacement therapy business outside of the US to Dr Reddy's Laboratories SA.

Read more
26 Jun 2024 12:49

Haleon to sell NRT business outside of the US to Dr Reddy's for £500m

(Sharecast News) - Haleon said on Wednesday that it has agreed to sell its nicotine replacement therapy (NRT) business outside of the US to Dr Reddy's Laboratories for £500m.

Read more
5 Jun 2024 09:52

LONDON BROKER RATINGS: Berenberg raises Taylor Wimpey to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

Read more
5 Jun 2024 08:49

Berenberg starts coverage of Haleon at 'buy'

(Sharecast News) - Berenberg initiated coverage of consumer health company Haleon on Wednesday with a 'buy' rating and 407p price target.

Read more
1 Jun 2024 21:35

Delaware judge lets more than 70,000 Zantac lawsuits go forward

June 1 (Reuters) - A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert witnesses can testify in court that the drug may cause cancer.

Read more
1 Jun 2024 21:07

Delaware judge lets more than 70,000 Zantac lawsuits go forward

June 1 (Reuters) - A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert witnesses can testify in court that the drug may cause cancer.

Read more
17 May 2024 17:38

London's FTSE nudges lower for week after record run

Haleon falls after GSK offloads remaining stake

*

Read more
17 May 2024 15:52

London close: Stocks recoup some earlier losses

(Sharecast News) - London stocks remained in negative territory by Friday's close, although they managed to recoup some of the losses seen earlier in the session as Wall Street opened with positive momentum.

Read more
17 May 2024 11:52

LONDON MARKET MIDDAY: FTSE 100 slides; Eurozone inflation steady

(Alliance News) - Stock prices in London were lacklustre at midday on Friday, as investors eye the trajectory of interest rates across the globe.

Read more
17 May 2024 09:03

TOP NEWS: GSK sells remaining Haleon stake for GBP1.25 billion

(Alliance News) - GSK PLC on Friday said it has sold its remaining shares in Haleon PLC, marking a total exit from its consumer healthcare spin-off.

Read more
17 May 2024 08:56

LONDON MARKET OPEN: FTSE 100 lacklustre as Wall Street rally ends

(Alliance News) - Stock prices in London opened lower on Friday, after Thursday saw Wall Street's rally end in a record breaking session.

Read more
17 May 2024 08:39

GSK raises $1.5 bln from sale of remaining Haleon stake

May 17 (Reuters) - British drugmaker GSK has raised 1.25 billion pounds ($1.52 billion) from a sale of its remaining stake in consumer healthcare company Haleon to institutional investors.

Read more
17 May 2024 07:42

LONDON BRIEFING: Land Securities ups dividend; GSK sells Haleon stake

(Alliance News) - Stocks in London are called to open lower, as investors wait for an inflation reading from the eurozone later this morning.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.